Voci, D., Götschi, A., Held, U., Bingisser, R., Colucci, G., Dürschmied, D., . . . Barco, S. (2023). Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial : full-length article. Thrombosis research, 221, . https://doi.org/10.1016/j.thromres.2022.10.021
Chicago-Zitierstil (17. Ausg.)Voci, Davide, et al. "Enoxaparin for Outpatients with COVID-19: 90-day Results from the Randomised, Open-label, Parallel-group, Multinational, Phase III OVID Trial : Full-length Article." Thrombosis Research 221 (2023). https://doi.org/10.1016/j.thromres.2022.10.021.
MLA-Zitierstil (9. Ausg.)Voci, Davide, et al. "Enoxaparin for Outpatients with COVID-19: 90-day Results from the Randomised, Open-label, Parallel-group, Multinational, Phase III OVID Trial : Full-length Article." Thrombosis Research, vol. 221, 2023, https://doi.org/10.1016/j.thromres.2022.10.021.